Johnson & Johnson plans Ebola vaccine testing

SHARE Johnson & Johnson plans Ebola vaccine testing

Johnson & Johnson will begin safety testing in early January on a vaccine combination that could protect people from a strain of the deadly Ebola virus. The health care products maker said Wednesday that the vaccine being developed by its Janssen Pharmaceutical Companies protects against an Ebola strain that is “highly similar” to the virus that has triggered the current outbreak in West Africa. Johnson & Johnson also plans to test whether its vaccine protects against the version causing the outbreak, which has killed more than 4,500 people.

Read more at Newsfeed.

The Latest
The 25-year-old catcher, who has outperformed Martin Maldinado in every aspect this season, could see his playing time accelerate as the season goes on.
Hendricks allowed four runs in four innings, lowering his ERA from 12.71 to 12.00.
Terry Anderson was chief Middle East correspondent for the AP when he was kidnapped in Beirut in 1985 by the militant group Hezbollah, who suspected he was a spy. His 1991 best-seller ‘Den of Lions’ chronicles his torture and time in captivity.
Happ probably could have started Sunday’s series finale with the Marlins. The risk, however, wasn’t worth the reward.
Asked before Sunday’s series finale against the Marlins if Alzolay is his closer, Cubs manager Craig Counsell said, “I don’t think today he would be.”